Daisaku Ashikari

437 total citations
13 papers, 345 citations indexed

About

Daisaku Ashikari is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Daisaku Ashikari has authored 13 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Daisaku Ashikari's work include Prostate Cancer Treatment and Research (7 papers), Ubiquitin and proteasome pathways (3 papers) and Pelvic floor disorders treatments (2 papers). Daisaku Ashikari is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Ubiquitin and proteasome pathways (3 papers) and Pelvic floor disorders treatments (2 papers). Daisaku Ashikari collaborates with scholars based in Japan, United States and Australia. Daisaku Ashikari's co-authors include Satoru Takahashi, Daisuke Obinata, Satoshi Inoue, Ken‐ichi Takayama, Tomohiko Urano, Tetsuya Fujimura, Yukio Homma, Kazuhiro Ikeda, Yuta Yamada and Yutaka Suzuki and has published in prestigious journals such as Oncogene, Clinical Cancer Research and European Journal of Cancer.

In The Last Decade

Daisaku Ashikari

13 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisaku Ashikari Japan 9 218 89 84 83 72 13 345
Maryann Mikhail United States 9 158 0.7× 52 0.6× 102 1.2× 94 1.1× 140 1.9× 16 365
Yixin Liu China 9 158 0.7× 104 1.2× 46 0.5× 70 0.8× 173 2.4× 25 362
Noga Bloushtain-Qimron United States 7 258 1.2× 52 0.6× 49 0.6× 130 1.6× 137 1.9× 8 375
Abhilasha Sinha United States 12 188 0.9× 72 0.8× 46 0.5× 55 0.7× 134 1.9× 17 300
Michal Vočka Czechia 11 144 0.7× 57 0.6× 43 0.5× 98 1.2× 141 2.0× 56 349
C Ludwig United States 6 215 1.0× 65 0.7× 45 0.5× 72 0.9× 86 1.2× 8 318
Tayyebeh M. Nazeran Canada 10 149 0.7× 83 0.9× 28 0.3× 84 1.0× 45 0.6× 13 433
Veena Gopalakrishnan Singapore 6 320 1.5× 50 0.6× 58 0.7× 89 1.1× 121 1.7× 8 451
Sijana H. Dzinic United States 11 311 1.4× 35 0.4× 48 0.6× 67 0.8× 80 1.1× 15 476
Teming Zhang China 6 135 0.6× 110 1.2× 114 1.4× 89 1.1× 160 2.2× 10 324

Countries citing papers authored by Daisaku Ashikari

Since Specialization
Citations

This map shows the geographic impact of Daisaku Ashikari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisaku Ashikari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisaku Ashikari more than expected).

Fields of papers citing papers by Daisaku Ashikari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisaku Ashikari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisaku Ashikari. The network helps show where Daisaku Ashikari may publish in the future.

Co-authorship network of co-authors of Daisaku Ashikari

This figure shows the co-authorship network connecting the top 25 collaborators of Daisaku Ashikari. A scholar is included among the top collaborators of Daisaku Ashikari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisaku Ashikari. Daisaku Ashikari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Keerthikumar, Shivakumar, Susanne Ramm, Daisaku Ashikari, et al.. (2024). Co‐targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor‐null prostate cancer. The Journal of Pathology. 263(2). 242–256. 7 indexed citations
2.
Yamamoto, Shinichiro, Ken‐ichi Takayama, Daisuke Obinata, et al.. (2019). Identification of new octamer transcription factor 1‐target genes upregulated in castration‐resistant prostate cancer. Cancer Science. 110(11). 3476–3485. 28 indexed citations
3.
Ashikari, Daisaku, Katsuhiko Sato, Shinobu Masuda, et al.. (2019). Ectopic adrenal adenoma causing gross hematuria: Steroidogenic enzyme profiling and literature review. IJU Case Reports. 2(3). 158–161. 3 indexed citations
4.
Ashikari, Daisaku, Ken‐ichi Takayama, Tomoaki Tanaka, et al.. (2017). Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer. Oncogene. 36(45). 6272–6281. 61 indexed citations
5.
Ashikari, Daisaku, Ken‐ichi Takayama, Daisuke Obinata, Satoru Takahashi, & Satoshi Inoue. (2017). CLDN 8 , an androgen‐regulated gene, promotes prostate cancer cell proliferation and migration. Cancer Science. 108(7). 1386–1393. 35 indexed citations
6.
Yamada, Yuta, Ken‐ichi Takayama, Tetsuya Fujimura, et al.. (2016). A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor. Cancer Science. 108(1). 32–41. 64 indexed citations
7.
Fujimura, Tetsuya, Satoshi Inoue, Tomohiko Urano, et al.. (2016). Increased Expression of Tripartite Motif (TRIM) 47 Is a Negative Prognostic Predictor in Human Prostate Cancer. Clinical Genitourinary Cancer. 14(4). 298–303. 33 indexed citations
8.
Obinata, Daisuke, Ken‐ichi Takayama, Tomohiko Urano, et al.. (2016). Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration. European Journal of Cancer. 57. 39–49. 23 indexed citations
9.
Sato, Katsuhiko, Daisuke Obinata, Yasutaka Murata, et al.. (2016). Efficacy of transurethral prostate enucleation by bipolar system for patients with benign prostatic hyperplasia.. PubMed. 68(4). 337–41. 8 indexed citations
10.
Ashikari, Daisaku, K. Takayama, Daisuke Obinata, et al.. (2015). 276 A novel androgen-responsive gene, G3BP2, induces therapeutic-resistance in castration-resistant prostate cancer cells. European Urology Supplements. 14(2). e276–e276. 1 indexed citations
11.
Obinata, Daisuke, Kyoko Fujiwara, Ken‐ichi Takayama, et al.. (2014). Pyrrole‐imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth. Cancer Science. 105(10). 1272–1278. 13 indexed citations
12.
Obinata, Daisuke, Kenya Yamaguchi, Yasutaka Murata, et al.. (2013). Lower urinary tract symptoms in female patients with pelvic organ prolapse: Efficacy of pelvic floor reconstruction. International Journal of Urology. 21(3). 301–307. 17 indexed citations
13.
Takayama, Ken‐ichi, Tomohiko Urano, Tetsuya Fujimura, et al.. (2012). 14-3-3ζ, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer and Promotes Prostate Cancer Cell Proliferation and Survival. Clinical Cancer Research. 18(20). 5617–5627. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026